|
|
|
|
|
|
|
|
|
|
|
|
|
|
For 14 WHO
regions, by age and sex
|
|
|
| Ø |
Comprehensive
reviews
|
|
|
|
l |
Prevalence of
risk factor exposure
|
|
|
|
l |
Size of the
‘hazard’ or association (relative risk)
|
|
| Ø |
Estimate
contribution of RF to disease
|
|
|
|
(attributable
fraction)
|
|
|
|
l |
Applying
potential impact fraction to burden of
|
|
|
|
disease estimates
in WHO GBD database
|
|
|
| Ø |
Counterfactual
analysis: using theoretical
|
|
|
|
minimum exposure
|
|